Key facts
- Oxford Medical Products’s last known valuation is $23.1M (Feb 2022).
- It has raised $5.5M; the latest was Later Stage VC in Apr 2025.
- Notable investors include Texas Medical Center, Ada Ventures, Nesta, Oxford Innovation Finance, Discovery Park Ventures — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Oxford Medical Products
- ·The full record, as it builds
Funding rounds
No funding rounds for Oxford Medical Products are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oxford Medical Products
Developer of a gastro-retentive hydrogel technology designed to reduce hunger and lead to significant weight loss. The company's technology provides capsules formulated to expand rapidly in the stomach, resulting in a feeling of satiety, and stay in the stomach for a prolonged period, break down gradually, and pass naturally, enabling people to lose weight.
- Sector
- Healthcare
- HQ
- Witney, United Kingdom
- Founded
- 2016
- Employees
- 21
- Website
- oxfordmedicalproducts.com/
- Ownership
- Privately Held (backing)
Oxford Medical Products doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oxford Medical Products shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oxford Medical Products in its N-PORT filings yet. We sweep new filings monthly.